RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. FCF margin (%)

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 202425.8-12.66%
Dec 31, 202329.5-18.72%
Dec 31, 202236.3-10.53%
Dec 31, 202140.6+72.30%
Dec 31, 202023.6-7.31%
Dec 31, 201925.4-5.78%
Dec 31, 201827+53.27%
Dec 31, 201717.6-10.94%
Dec 31, 201619.8+24.34%
Dec 31, 201515.9+9.36%
Dec 31, 201414.5-28.35%
Dec 31, 201320.3-325.79%
Dec 31, 2012-9-79.84%
Dec 31, 2011-44.6+6022.88%
Dec 31, 2010-0.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)